Celogics
PrivateLast Round
Corporate Funding
Oct 26, 2021
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Celogics is a biotechnology company that develops, manufactures, and commercializes human induced pluripotent stem cell (iPSC)-derived cell products for drug discovery, safety testing, and biological research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Celogics Comparables
Compare Celogics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Axol Bioscience | 82% | |
| bit.bio | 81% | |
| iXCells Biotechnologies | 81% |
Celogics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Oct 26, 2021 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 62% MoM.
- Apr 6, 2026
Monthly visitors grew 58% MoM, from 1.2K to 2K.
Celogics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Celogics's valuation, stock price, and market status.
Is Celogics a public or private company?
Celogics is a private company.
What is the current stock price of Celogics?
Celogics is a private company, so its shares have no public market price. Caplight tracks Celogics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Celogics worth (valuation)?
Valuation information for Celogics is not publicly available.
Can I buy Celogics stock?
Celogics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Celogics's last funding round?
Celogics's most recent funding round was Corporate Funding on October 26, 2021.
Who are the main investors in Celogics?
Investor information for Celogics is not publicly disclosed.
Will Celogics IPO soon?
No public IPO plans have been announced for Celogics.
How can I track Celogics secondary market activity?
Caplight tracks bids, offers, and trades in Celogics's shares on secondary markets.